Name: Latest research reports of Senores Pharmaceuticals Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Senores Pharmaceuticals Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Senores Pharmaceuticals Ltd.

NSE: SENORES | BSE: 544319 | ISIN: INE0RB801010 | Industry: Pharmaceuticals
| Mid-range Performer

1174.6000 -42.40 (-3.48%)

NSE Nov 13, 2026 15:31 PM

26.54% Fall from 52W High

Volume: 409.5K

Senores Pharmaceuticals Ltd.

22 Aug 2025

1174.60

-3.48%

ERRATA: [Initiation] Senores Pharma (BUY): Earnings buoyancy to continue

Buy: Senores Pharmaceuticals Ltd.

BOB Capital Markets Ltd.

Expect Revenue per ANDA to grow by 5% CAGR from FY25-28E to Rs 114 mn in FY28 vs Rs 99 mn in FY25

Senores Pharmaceuticals Ltd. is trading below its 30 day SMA of 1247.0